116 related articles for article (PubMed ID: 1827811)
1. Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.
Phillips RA; Ardeljan M; Shimabukuro S; Goldman ME; Garbowit DL; Eison HB; Krakoff LR
J Am Coll Cardiol; 1991 Jun; 17(7):1595-602. PubMed ID: 1827811
[TBL] [Abstract][Full Text] [Related]
2. Effects of nifedipine-GITS on left ventricular mass and left ventricular filling.
Phillips RA; Ardeljan M; Shimabukuro S; Goldman ME; Garbowit DL; Eison HB; Krakoff LR
J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S28-34. PubMed ID: 1377301
[TBL] [Abstract][Full Text] [Related]
3. Effect of nifedipine GITS on left ventricular mass and diastolic function in severe hypertension.
Phillips RA; Ardeljan M; Shimabukuro S; Goldman ME; Garbowit DL; Eison HB; Krakoff LR
J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S172-4. PubMed ID: 1715475
[TBL] [Abstract][Full Text] [Related]
4. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
[TBL] [Abstract][Full Text] [Related]
5. Effects of sustained-release nicardipine on regression of left ventricular hypertrophy in systemic hypertension.
Dittrich HC; Adler J; Ong J; Reitman M; Weber M; Ziegler M
Am J Cardiol; 1992 Jun; 69(19):1559-64. PubMed ID: 1534642
[TBL] [Abstract][Full Text] [Related]
6. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
[TBL] [Abstract][Full Text] [Related]
7. The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
Ueno H; Takata M; Tomita S; Oh-hashi S; Yasumoto K; Inoue H
J Cardiovasc Pharmacol; 1997 Nov; 30(5):643-8. PubMed ID: 9388047
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
[TBL] [Abstract][Full Text] [Related]
10. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Drugs; 1988; 35 Suppl 4():39-43. PubMed ID: 2967752
[TBL] [Abstract][Full Text] [Related]
11. Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension.
de Simone G; Devereux RB; Volpe M; Camargo MJ; Wallerson DC; Laragh JH
Am J Hypertens; 1992 May; 5(5 Pt 1):292-301. PubMed ID: 1533770
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
Colantonio D; Casale R; Desiati P; Giandomenico G; Bucci V; Pasqualetti P
J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy by acebutolol and nifedipine.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():313-7. PubMed ID: 2535068
[TBL] [Abstract][Full Text] [Related]
14. Etiology, pathophysiology, and treatment of left ventricular hypertrophy: focus on severe hypertension.
Phillips RA
J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S55-62. PubMed ID: 7692152
[TBL] [Abstract][Full Text] [Related]
15. Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension.
Fagard RH; Lijnen PJ; Petrov VV
J Hum Hypertens; 1998 Mar; 12(3):195-202. PubMed ID: 9579770
[TBL] [Abstract][Full Text] [Related]
16. [Effects of calcium antagonists or beta-blockade on left ventricular diastolic function in essential hypertension].
Shiotani M; Arita M; Nakatsu C; Nakamura N; Ohshika H; Nakamura Y; Fujiwara S; Ueno Y; Nishio I; Masuyama Y
J Cardiol; 1990; 20(1):135-45. PubMed ID: 2093746
[TBL] [Abstract][Full Text] [Related]
17. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
[TBL] [Abstract][Full Text] [Related]
18. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension.
Yasumoto K; Takata M; Ueno H; Tomita S; Tomoda F; Inoue H
Am J Hypertens; 1999 Sep; 12(9 Pt 1):921-4. PubMed ID: 10509551
[TBL] [Abstract][Full Text] [Related]
19. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
[TBL] [Abstract][Full Text] [Related]
20. Assessment of left ventricular function after sublingual administration of nifedipine in patients with moderate to severe hypertension.
Hayashi H; Iwase M; Aoki T; Yokota M
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():969-75. PubMed ID: 2150175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
